Monitor future 13G amendments for stake increases or decreases; State Street's passive position is consistent with index fund management and does not signal a strategic view on the stock.
MNKD drugs
MNKD drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 10 $4.23entry
- T+1 · 6d ago −0.95%α −2.26% · $4.19
- T+4 · todayOpen
- T+5 · in 9h Pending
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
State Street Corp filed a Schedule 13G disclosing a 4.7% passive stake in MannKind Corp as of September 30, 2026, representing 15,096,712 shares. This is a routine passive filing by a large institutional custodian and asset manager, with no activist intent. The filing follows MannKind's Q3 2026 earnings release showing 24% revenue growth driven by the Furoscix launch, though the company reported a GAAP net loss versus a year-ago profit.
Key Financial Metrics
Key Facts
- State Street Corp disclosed beneficial ownership of 15,096,712 shares of MannKind Corp common stock as of September 30, 2026
- The stake represents 4.7% of shares outstanding
- Filing is made under Rule 13d-1(b), certifying passive investment intent with no purpose of changing or influencing control
- State Street is a large institutional custodian/bank holding company, not an activist investor
- This is State Street's second SC 13G filing for MannKind; a prior filing was made on May 12, 2026
Financial Impact
Stake valued at approximately $61M based on market cap of $1.3B and 4.7% ownership
Risk Factors
- No material risks identified from this passive filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0000093751-26-000688 |
| Document: 0000093751-26-000688-index.html | 0000093751-26-000688 |
| Document: 0000093751-26-000688.txt | 0000093751-26-000688 |
Track record
17 reports on MNKD
7 of 8 bullish or bearish reports moved the stock their way by T+20. Best: +20.00% at T+60 after the May 27, 2026 report. 8 of 9 went positive at some point.
Filters
- Nov 10, 20266d ago SC 13G Neutral 3/10 Viewing Entry $4.23 Now $3.96 −6.38% settles Dec 9
- Nov 5, 202611d ago 8-K Neutral 5/10 No price data
- Nov 5, 202611d ago Press Release Bearish 5/10 Entry $3.90 Now $3.96 −1.54% settles Dec 7
- Nov 2, 202614d ago Institutional Cluster Neutral 2/10 Entry $3.73 Now $3.96 +6.17% settles Dec 2
- Jul 29, 202615w ago Press Release Bullish 6/10 Entry $3.85 to $4.09 Now $3.96 +2.86% ▲ +6.23% +1.21% vs SPY
- Jul 24, 202616w ago 8-K Mixed 6/10 Entry $3.95 to $4.07 Now $3.96 +0.25% ▲ +3.04% −0.26% vs SPY
- Jul 17, 202617w ago Insider Cluster Neutral 3/10 Entry $3.98 to $3.90 Now $3.96 −0.50% ▼ −2.01% −6.13% vs SPY
- Jun 3, 202623w ago Press Release Neutral 5/10 Entry $3.36 to $4.52 Now $3.96 +17.86% ▲ +34.52% +35.52% vs SPY
- Jun 2, 202623w ago 8-K Bullish 7/10 Entry $3.43 to $4.05 Now $3.96 +15.45% ▲ +18.08% +19.64% vs SPY
- May 29, 202624w ago Press Release Bullish 8/10 Entry $3.77 to $4.24 Now $3.96 +5.04% ▲ +12.47% +14.26% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers